IMPACT THERAP-B (07630) is scheduled to list on the Hong Kong stock exchange on Wednesday, May 13. At the time of writing, pre-market trading indicates a price of HK$44.06, representing a surge of 119.2% from its IPO price of HK$20.1. With each lot comprising 200 shares, the profit per lot, excluding transaction fees, amounts to HK$4,792.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments